BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 2549926)

  • 1. Ouabain binding in the human brain. Effects of Alzheimer's disease and aging.
    Harik SI; Mitchell MJ; Kalaria RN
    Arch Neurol; 1989 Sep; 46(9):951-4. PubMed ID: 2549926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific ouabain binding to brain microvessels and choroid plexus.
    Harik SI; Doull GH; Dick AP
    J Cereb Blood Flow Metab; 1985 Mar; 5(1):156-60. PubMed ID: 2982890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aging: effects on sodium- and potassium-activated adenosine triphosphatase activity and ouabain binding sites in rat brain.
    Kennedy RH; Akera T; Katano Y
    J Gerontol; 1985 Jul; 40(4):401-8. PubMed ID: 2989353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of rat cerebral cortex Na+,K(+)-ATPase: effect of age and potassium depletion.
    Schmidt TA; Larsen JS; Kjeldsen K
    J Neurochem; 1992 Dec; 59(6):2094-104. PubMed ID: 1331324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in adrenergic receptors of frontal cortex and cerebral microvessels in Alzheimer's disease and aging.
    Kalaria RN; Andorn AC; Harik SI
    Prog Clin Biol Res; 1989; 317():367-74. PubMed ID: 2557637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a very-high-affinity ouabain binding site in term fetal guinea pig brain Na+,K(+)-ATPase.
    Graham EM; Mishra OP; Delivoria-Papadopoulos M
    J Soc Gynecol Investig; 1998; 5(1):2-5. PubMed ID: 9501291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adrenergic receptors in aging and Alzheimer's disease: decreased alpha 2-receptors demonstrated by [3H]p-aminoclonidine binding in prefrontal cortex.
    Kalaria RN; Andorn AC
    Neurobiol Aging; 1991; 12(2):131-6. PubMed ID: 1646966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of redox, polyamine, and glycine modulatory domains of the N-methyl-D-aspartate receptor in Alzheimer's disease.
    Palmer AM; Burns MA
    J Neurochem; 1994 Jan; 62(1):187-96. PubMed ID: 8263519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Na+-K+)-ATPase activity and ouabain-binding sites in the cerebral cortex of young and aged Fischer-344 rats.
    LaManna JC; Doull G; McCracken K; Harik SI
    Gerontology; 1983; 29(4):242-7. PubMed ID: 6307830
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transferrin receptors of rat and human brain and cerebral microvessels and their status in Alzheimer's disease.
    Kalaria RN; Sromek SM; Grahovac I; Harik SI
    Brain Res; 1992 Jul; 585(1-2):87-93. PubMed ID: 1511337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic receptors in aging and Alzheimer's disease: increased beta 2-receptors in prefrontal cortex and hippocampus.
    Kalaria RN; Andorn AC; Tabaton M; Whitehouse PJ; Harik SI; Unnerstall JR
    J Neurochem; 1989 Dec; 53(6):1772-81. PubMed ID: 2553864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease.
    Kalaria RN; Harik SI
    J Neurochem; 1989 Oct; 53(4):1083-8. PubMed ID: 2769254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of [125I]HEAT binding to alpha 1-receptors in human brain: assessment in aging and Alzheimer's disease.
    Kalaria RN
    Brain Res; 1989 Nov; 501(2):287-94. PubMed ID: 2555022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Saturable adenosine 5'-triphosphate-independent binding of [3H]-ouabain to brain and cardiac tissue in vitro.
    Akera T; Brody TM; Wiest SA
    Br J Pharmacol; 1979 Mar; 65(3):403-9. PubMed ID: 218666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related changes in [3H] ouabain binding to synaptic plasma membranes isolated from mouse brains.
    Tanaka Y; Ando S
    J Biochem; 1992 Jul; 112(1):117-21. PubMed ID: 1331033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blood--brain barrier sodium/potassium pump: modulation by central noradrenergic innervation.
    Harik SI
    Proc Natl Acad Sci U S A; 1986 Jun; 83(11):4067-70. PubMed ID: 3012548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal.
    Flynn DD; Mash DC
    J Neurochem; 1986 Dec; 47(6):1948-54. PubMed ID: 3772387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of "high-affinity" [3H]ouabain binding in the rat central nervous system.
    Hauger R; Luu HM; Meyer DK; Goodwin FK; Paul SM
    J Neurochem; 1985 Jun; 44(6):1709-15. PubMed ID: 2985761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormalities of the glucose transporter at the blood-brain barrier and in brain in Alzheimer's disease.
    Kalaria RN; Harik SI
    Prog Clin Biol Res; 1989; 317():415-21. PubMed ID: 2602426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoradiographic visualization and characterization of [3H]ouabain binding to the Na+,K+-ATPase of rat brain and pineal.
    Caspers ML; Schwartz RD; Labarca R; Paul SM
    Brain Res; 1987 Apr; 409(2):335-42. PubMed ID: 3034380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.